• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性癌症:重访“两次打击”学说

Hereditary cancer: two hits revisited.

作者信息

Knudson A G

机构信息

Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA USA.

出版信息

J Cancer Res Clin Oncol. 1996;122(3):135-40. doi: 10.1007/BF01366952.

DOI:10.1007/BF01366952
PMID:8601560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12201814/
Abstract

According to a "two-hit" model, dominantly inherited predisposition to cancer entails a germline mutation, while tumorigenesis requires a second, somatic, mutation. Non-hereditary cancer of the same type requires the same two hits, but both are somatic. The original tumor used in this model, retinoblastoma, involves mutation or loss of both are somatic. The original tumor used in this model, retinoblastoma, involves mutation or loss of both copies of the RB1 tumor-suppressor gene in both hereditary and non-hereditary forms. In fact, most dominantly inherited cancers show this relationship. New dominantly inherited cancers show this relationship. New questions have arisen, however. When a tumor-suppressor gene is ubiquitously expressed, why is there any specificity of tumor predilection? In some instances, it is clear that two hits produce only a benign precursor lesion and that other genetic events are necessary. As the number of necessary events increase, the impact of the germline mutation diminishes. The number of events is least for embryonal tumors, and relatively small for certain sarcomas. Stem-cell proliferation evidently plays a key role early in carcinogenesis. In some tissues it is physiological, as in embryonic development and in certain tissues in adolescence. In adult renewal tissues, the sites of the common carcinomas, mutation may be necessary to impair the control of switching between renewal and replicative cell divisions; the APC gene may be the target of such a mutation.

摘要

根据“两次打击”模型,癌症的显性遗传易感性需要种系突变,而肿瘤发生则需要第二次体细胞突变。同一类型的非遗传性癌症也需要同样的两次打击,但两者都是体细胞性的。该模型中最初使用的肿瘤——视网膜母细胞瘤,在遗传性和非遗传性形式中都涉及RB1肿瘤抑制基因两个拷贝的突变或缺失。事实上,大多数显性遗传癌症都呈现这种关系。然而,新的问题出现了。当一个肿瘤抑制基因普遍表达时,为什么会有肿瘤偏好的特异性呢?在某些情况下,很明显两次打击只会产生良性前体病变,还需要其他遗传事件。随着所需事件数量的增加,种系突变的影响会减小。胚胎性肿瘤所需的事件数量最少,某些肉瘤所需的事件数量相对较少。干细胞增殖显然在致癌早期起着关键作用。在某些组织中,这是生理性的,如在胚胎发育和青春期的某些组织中。在成体更新组织(常见癌症的发生部位)中,可能需要突变来损害更新和复制性细胞分裂之间转换的控制;APC基因可能是这种突变的靶点。

相似文献

1
Hereditary cancer: two hits revisited.遗传性癌症:重访“两次打击”学说
J Cancer Res Clin Oncol. 1996;122(3):135-40. doi: 10.1007/BF01366952.
2
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
Idiopathic (Genetic) Generalized Epilepsy特发性(遗传性)全身性癫痫
5
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
6
Short-Term Memory Impairment短期记忆障碍
7
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
8
Sexual Harassment and Prevention Training性骚扰与预防培训
9
Beckwith-Wiedemann Syndrome贝克威思-维德曼综合征
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

引用本文的文献

1
Risk Analysis of Retinal Hemangioblastomas in Nonadvanced Stages of von Hippel-Lindau Syndrome Using Ultra-widefield Imaging: The ULTRA von Hippel-Lindau Study.使用超广角成像技术对冯·希佩尔-林道综合征非晚期视网膜血管母细胞瘤的风险分析:ULTRA冯·希佩尔-林道研究
Ophthalmol Sci. 2025 Jun 9;5(6):100846. doi: 10.1016/j.xops.2025.100846. eCollection 2025 Nov-Dec.
2
YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies.YTHDF2促进B细胞恶性肿瘤中的ATP合成和免疫逃逸。
Cell. 2025 Jan 23;188(2):331-351.e30. doi: 10.1016/j.cell.2024.11.007. Epub 2024 Dec 17.
3
A Destroyer of Tissues: A Case of Chronic Low-Dose Radiation Exposure and the Need for Frequent Screening in Exposed Populations.组织破坏者:一例慢性低剂量辐射暴露病例及对受暴露人群进行频繁筛查的必要性
Cureus. 2024 Nov 1;16(11):e72845. doi: 10.7759/cureus.72845. eCollection 2024 Nov.
4
A systematic review of candidate genes and their relevant pathways for metastasis among adults diagnosed with breast cancer.一项针对成年乳腺癌患者转移相关候选基因及其相关途径的系统评价。
Breast Cancer Res. 2024 Nov 26;26(1):165. doi: 10.1186/s13058-024-01914-6.
5
Molecular profiling reveals novel therapeutic targets and clonal evolution in ovarian clear cell carcinoma.分子谱分析揭示了卵巢透明细胞癌的新治疗靶点和克隆进化。
BMC Cancer. 2024 Nov 14;24(1):1403. doi: 10.1186/s12885-024-13125-5.
6
Advances in Molecular Mechanisms of Kidney Disease: Integrating Renal Tumorigenesis of Hereditary Cancer Syndrome.肾脏疾病分子机制的研究进展:遗传性癌症综合征相关肾肿瘤的发生机制。
Int J Mol Sci. 2024 Aug 21;25(16):9060. doi: 10.3390/ijms25169060.
7
Medullary Thyroid Cancer: Molecular Drivers and Immune Cellular Milieu of the Tumour Microenvironment-Implications for Systemic Treatment.甲状腺髓样癌:肿瘤微环境的分子驱动因素与免疫细胞环境——对全身治疗的启示
Cancers (Basel). 2024 Jun 22;16(13):2296. doi: 10.3390/cancers16132296.
8
PM2.5, vegetation density, and childhood cancer: a case-control registry-based study from Texas 1995-2011.PM2.5、植被密度与儿童癌症:得克萨斯州 1995-2011 年基于病例对照登记研究
J Natl Cancer Inst. 2024 Jun 7;116(6):876-884. doi: 10.1093/jnci/djae035.
9
Exome Sequencing Reveals Novel Germline Variants in Breast Cancer Patients in the Southernmost Region of Thailand.外显子组测序揭示泰国最南端地区乳腺癌患者的新型种系变异。
J Pers Med. 2023 Nov 9;13(11):1587. doi: 10.3390/jpm13111587.
10
The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis.患有NF2型神经鞘瘤病患者的脑膜瘤的临床、遗传和免疫特征
Neurooncol Adv. 2023 Jun 3;5(Suppl 1):i94-i104. doi: 10.1093/noajnl/vdac127. eCollection 2023 May.

本文引用的文献

1
The APC gene product in normal and tumor cells.正常细胞和肿瘤细胞中的APC基因产物。
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2846-50. doi: 10.1073/pnas.90.7.2846.
2
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.遗传性非息肉病性结直肠癌中一种MutS同源物的突变
Cell. 1993 Dec 17;75(6):1215-25. doi: 10.1016/0092-8674(93)90330-s.
3
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.人类错配修复基因同源物MSH2及其与遗传性非息肉病性结直肠癌的关联。
Cell. 1993 Dec 3;75(5):1027-38. doi: 10.1016/0092-8674(93)90546-3.
4
Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer.DNA错配修复基因同源物hMLH1的突变与遗传性非息肉病性结直肠癌相关。
Nature. 1994 Mar 17;368(6468):258-61. doi: 10.1038/368258a0.
5
Mutation of a mutL homolog in hereditary colon cancer.遗传性结肠癌中mutL同源物的突变
Science. 1994 Mar 18;263(5153):1625-9. doi: 10.1126/science.8128251.
6
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.RET原癌基因的突变与2A型多发性内分泌腺瘤病和家族性甲状腺髓样癌相关。
Hum Mol Genet. 1993 Jul;2(7):851-6. doi: 10.1093/hmg/2.7.851.
7
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.2A型多发性内分泌腺瘤病中RET原癌基因的种系突变。
Nature. 1993 Jun 3;363(6428):458-60. doi: 10.1038/363458a0.
8
BRCA1 mutations in primary breast and ovarian carcinomas.原发性乳腺癌和卵巢癌中的BRCA1基因突变。
Science. 1994 Oct 7;266(5182):120-2. doi: 10.1126/science.7939630.
9
p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma.p53蛋白在溃疡性结肠炎相关结直肠发育异常及癌中的表达
Hum Pathol. 1994 Oct;25(10):1069-74. doi: 10.1016/0046-8177(94)90067-1.
10
Antioncogenes and human cancer.抗癌基因与人类癌症。
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):10914-21. doi: 10.1073/pnas.90.23.10914.